| 000 | 01710 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518013002.0 | ||
| 264 | 0 | _c20190520 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1791-244X | ||
| 024 | 7 |
_a10.3892/ijmm.2018.4019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTian, Faqing | |
| 245 | 0 | 0 |
_aMicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2. _h[electronic resource] |
| 260 |
_bInternational journal of molecular medicine _cFeb 2019 |
||
| 300 |
_a1058-1066 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBortezomib _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xgenetics |
| 650 | 0 | 4 | _aCell Cycle Checkpoints |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xgenetics |
| 650 | 0 | 4 |
_aCell Survival _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aEctopic Gene Expression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 | _aRNA Interference |
| 700 | 1 | _aZhan, Yong | |
| 700 | 1 | _aZhu, Wei | |
| 700 | 1 | _aLi, Juheng | |
| 700 | 1 | _aTang, Meiqin | |
| 700 | 1 | _aChen, Xiaohui | |
| 700 | 1 | _aJiang, Jian | |
| 773 | 0 |
_tInternational journal of molecular medicine _gvol. 43 _gno. 2 _gp. 1058-1066 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijmm.2018.4019 _zAvailable from publisher's website |
| 999 |
_c29148668 _d29148668 |
||